Acorda Therapeutics Inc (ACORQ)
0.80
-0.05
(-5.88%)
USD |
OTCM |
May 06, 13:45
Acorda Therapeutics Cash from Investing (Quarterly): -0.044M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.044M |
| September 30, 2023 | -0.22M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.123M |
| September 30, 2022 | -0.15M |
| June 30, 2022 | -0.07M |
| March 31, 2022 | -0.039M |
| December 31, 2021 | -0.001M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.136M |
| March 31, 2021 | 73.92M |
| December 31, 2020 | 5.019M |
| September 30, 2020 | 20.15M |
| June 30, 2020 | 23.15M |
| March 31, 2020 | 11.04M |
| December 31, 2019 | 56.00M |
| September 30, 2019 | -3.276M |
| June 30, 2019 | -35.11M |
| March 31, 2019 | -18.12M |
| December 31, 2018 | -14.83M |
| September 30, 2018 | -2.71M |
| June 30, 2018 | -47.75M |
| March 31, 2018 | -111.58M |
| December 31, 2017 | -0.049M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.71M |
| June 30, 2017 | -3.105M |
| March 31, 2017 | -5.849M |
| December 31, 2016 | -0.316M |
| September 30, 2016 | -2.223M |
| June 30, 2016 | -269.56M |
| March 31, 2016 | 198.31M |
| December 31, 2015 | 31.04M |
| September 30, 2015 | -10.16M |
| June 30, 2015 | 9.92M |
| March 31, 2015 | -116.04M |
| December 31, 2014 | 106.96M |
| September 30, 2014 | -262.76M |
| June 30, 2014 | -126.59M |
| March 31, 2014 | -11.44M |
| December 31, 2013 | -17.87M |
| September 30, 2013 | -23.28M |
| June 30, 2013 | -2.761M |
| March 31, 2013 | -1.172M |
| December 31, 2012 | -15.87M |
| September 30, 2012 | -44.92M |
| June 30, 2012 | -3.089M |
| March 31, 2012 | -7.406M |
| December 31, 2011 | -18.94M |
| September 30, 2011 | -46.88M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-35.11M
Minimum
Jun 2019
73.92M
Maximum
Mar 2021
7.913M
Average
--
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
| BioSig Technologies Inc | -0.004M |
| Verve Therapeutics Inc | -8.893M |
| Spectral AI Inc | -- |
| AIM ImmunoTech Inc | -0.214M |
| Protalix BioTherapeutics Inc | -0.342M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.018M |
| Free Cash Flow | -14.25M |
| Free Cash Flow Per Share (Quarterly) | -2.465 |
| Free Cash Flow to Equity (Quarterly) | -8.162M |
| Free Cash Flow to Firm (Quarterly) | 3.732M |
| Free Cash Flow Yield | -1.44K% |